Home NDC 42783-510 NDC 42783-510 - NicAzelFORTE This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 42783-510
Package NDCs from labels 42783-510-60, 42783-510-04
Manufacturer Elorac, Inc
Effective date 2021-12-08
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Labels# Label, Manufacturer, Effective date table Label Manufacturer Effective date Type NicAzelFORTE - Elorac, Inc Elorac, Inc 2021-12-08 DIETARY SUPPLEMENT
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 42783-510-04 NicAzelFORTE 4 in 1 BOTTLE TABLET 4 25 42783-510-60 NicAzelFORTE 60 in 1 BOTTLE TABLET 60 25
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 42783-510 NICAZELFORTE (AZERIZIN, PYRIDOXINE, ZINC, COPPER, FOLIC ACID) TABLET [ELORAC, INC] 25 2 package rows 20211209_bea888b4-9cc6-49da-89e6-5c273b974ed1.zip
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CUPRIC OXIDE ACTIVE INGREDIENT V1XJQ704R4 NICAZELFORTE (AZERIZIN, PYRIDOXINE, ZINC, COPPER, FOLIC ACID) TABLET [ELORAC, INC] 5 FOLIC ACID ACTIVE INGREDIENT 935E97BOY8 NICAZELFORTE (AZERIZIN, PYRIDOXINE, ZINC, COPPER, FOLIC ACID) TABLET [ELORAC, INC] 5 PYRIDOXINE ACTIVE INGREDIENT KV2JZ1BI6Z NICAZELFORTE (AZERIZIN, PYRIDOXINE, ZINC, COPPER, FOLIC ACID) TABLET [ELORAC, INC] 5 ZINC OXIDE ACTIVE INGREDIENT SOI2LOH54Z NICAZELFORTE (AZERIZIN, PYRIDOXINE, ZINC, COPPER, FOLIC ACID) TABLET [ELORAC, INC] 5 CUPRIC CATION ACTIVE MOIETY 8CBV67279L NICAZELFORTE (AZERIZIN, PYRIDOXINE, ZINC, COPPER, FOLIC ACID) TABLET [ELORAC, INC] 5 FOLIC ACID ACTIVE MOIETY 935E97BOY8 NICAZELFORTE (AZERIZIN, PYRIDOXINE, ZINC, COPPER, FOLIC ACID) TABLET [ELORAC, INC] 5 PYRIDOXINE ACTIVE MOIETY KV2JZ1BI6Z NICAZELFORTE (AZERIZIN, PYRIDOXINE, ZINC, COPPER, FOLIC ACID) TABLET [ELORAC, INC] 5 ZINC CATION ACTIVE MOIETY 13S1S8SF37 NICAZELFORTE (AZERIZIN, PYRIDOXINE, ZINC, COPPER, FOLIC ACID) TABLET [ELORAC, INC] 5 DIBASIC CALCIUM PHOSPHATE DIHYDRATE INACTIVE INGREDIENT O7TSZ97GEP NICAZELFORTE (AZERIZIN, PYRIDOXINE, ZINC, COPPER, FOLIC ACID) TABLET [ELORAC, INC] 5 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD NICAZELFORTE (AZERIZIN, PYRIDOXINE, ZINC, COPPER, FOLIC ACID) TABLET [ELORAC, INC] 5 FD&C YELLOW NO. 5 INACTIVE INGREDIENT I753WB2F1M NICAZELFORTE (AZERIZIN, PYRIDOXINE, ZINC, COPPER, FOLIC ACID) TABLET [ELORAC, INC] 5 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 NICAZELFORTE (AZERIZIN, PYRIDOXINE, ZINC, COPPER, FOLIC ACID) TABLET [ELORAC, INC] 5 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 NICAZELFORTE (AZERIZIN, PYRIDOXINE, ZINC, COPPER, FOLIC ACID) TABLET [ELORAC, INC] 5 POLYETHYLENE GLYCOLS INACTIVE INGREDIENT 3WJQ0SDW1A NICAZELFORTE (AZERIZIN, PYRIDOXINE, ZINC, COPPER, FOLIC ACID) TABLET [ELORAC, INC] 5 POLYVINYL ALCOHOL INACTIVE INGREDIENT 532B59J990 NICAZELFORTE (AZERIZIN, PYRIDOXINE, ZINC, COPPER, FOLIC ACID) TABLET [ELORAC, INC] 5 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 NICAZELFORTE (AZERIZIN, PYRIDOXINE, ZINC, COPPER, FOLIC ACID) TABLET [ELORAC, INC] 5 STEARIC ACID INACTIVE INGREDIENT 4ELV7Z65AP NICAZELFORTE (AZERIZIN, PYRIDOXINE, ZINC, COPPER, FOLIC ACID) TABLET [ELORAC, INC] 5 TALC INACTIVE INGREDIENT 7SEV7J4R1U NICAZELFORTE (AZERIZIN, PYRIDOXINE, ZINC, COPPER, FOLIC ACID) TABLET [ELORAC, INC] 5 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP NICAZELFORTE (AZERIZIN, PYRIDOXINE, ZINC, COPPER, FOLIC ACID) TABLET [ELORAC, INC] 5
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 21 of 278 · 5,547 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.